Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 3
2018 2
2019 1
2022 3
2023 3
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean N. beygui (81 results)?
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson M, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Oluwole OO, Yakoub-Agha I, Khanal R, Rosenblatt J, Korn R, Peng W, Lui C, Wulff J, Shen R, Poddar S, Jung AS, Miao H, Beygi S, Jacobson CA. Neelapu SS, et al. Blood. 2024 Feb 8;143(6):496-506. doi: 10.1182/blood.2023021243. Blood. 2024. PMID: 37879047 Free PMC article.
Approval was supported by the phase 2, multicenter, single-arm ZUMA-5 study of axi-cel for patients with R/R indolent non-Hodgkin lymphoma (iNHL; N = 104), including FL and marginal zone lymphoma (MZL). In the primary analysis (median follow-up, 17.5 months), the overall r …
Approval was supported by the phase 2, multicenter, single-arm ZUMA-5 study of axi-cel for patients with R/R indolent non-Hodgkin lymphoma ( …
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Sworder BJ, Kurtz DM, Alig SK, Frank MJ, Shukla N, Garofalo A, Macaulay CW, Shahrokh Esfahani M, Olsen MN, Hamilton J, Hosoya H, Hamilton M, Spiegel JY, Baird JH, Sugio T, Carleton M, Craig AFM, Younes SF, Sahaf B, Sheybani ND, Schroers-Martin JG, Liu CL, Oak JS, Jin MC, Beygi S, Hüttmann A, Hanoun C, Dührsen U, Westin JR, Khodadoust MS, Natkunam Y, Majzner RG, Mackall CL, Diehn M, Miklos DB, Alizadeh AA. Sworder BJ, et al. Cancer Cell. 2023 Jan 9;41(1):210-225.e5. doi: 10.1016/j.ccell.2022.12.005. Epub 2022 Dec 29. Cancer Cell. 2023. PMID: 36584673 Free PMC article.
To characterize determinants of resistance, we profiled over 700 longitudinal specimens from two independent cohorts (n = 65 and n = 73) of r/rLBCL patients treated with axicabtagene ciloleucel. A method for simultaneous profiling of circulating tumor DNA (ctDNA), c …
To characterize determinants of resistance, we profiled over 700 longitudinal specimens from two independent cohorts (n = 65 and n …
Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma.
Ray MD, Kanters S, Beygi S, Best T, Wulff J, Limbrick-Oldfield E, Patel AR, Oluwole OO. Ray MD, et al. Transplant Cell Ther. 2024 Sep;30(9):885.e1-885.e11. doi: 10.1016/j.jtct.2024.06.016. Epub 2024 Jun 19. Transplant Cell Ther. 2024. PMID: 38901633 Free article.
Patient characteristics were well-aligned between trials leading to large effective-sample sizes after matching, ranging from 93.4 to 115.5, for ZUMA-5 (n = 127). In comparisons to mosunetuzumab (n = 90), axi-cel was associated with improved PFS (HR: 0.39; 95% confi …
Patient characteristics were well-aligned between trials leading to large effective-sample sizes after matching, ranging from 93.4 to 115.5, …
Halide-, Hybrid-, and Perovskite-Functionalized Light Absorbing Quantum Materials of p-i-n Heterojunction Solar Cells.
Beygi H, Sajjadi SA, Babakhani A, Young JF, van Veggel FCJM. Beygi H, et al. ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30283-30295. doi: 10.1021/acsami.8b06967. Epub 2018 Aug 27. ACS Appl Mater Interfaces. 2018. PMID: 30107115
The p-i-n quantum dot (QD) solar cells were fabricated through the single-step deposition of both of its p-type and light absorbing quantum layers. The hole transport and light absorbing layers of these devices were made by the p- and n-type PbS QDs, which were func …
The p-i-n quantum dot (QD) solar cells were fabricated through the single-step deposition of both of its p-type and light absorbing q …
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma.
Beygi S, Duran GE, Fernandez-Pol S, Rook AH, Kim YH, Khodadoust MS. Beygi S, et al. Blood. 2022 Jun 30;139(26):3732-3736. doi: 10.1182/blood.2021014468. Blood. 2022. PMID: 35436328 Free PMC article.
Novel emergent CCR4 mutations targeting the N-terminal and transmembrane domains were found in 3 patients after disease progression. ...
Novel emergent CCR4 mutations targeting the N-terminal and transmembrane domains were found in 3 patients after disease progression. …
Fabrication of a Monolithic Implantable Neural Interface from Cubic Silicon Carbide.
Beygi M, Bentley JT, Frewin CL, Kuliasha CA, Takshi A, Bernardin EK, La Via F, Saddow SE. Beygi M, et al. Micromachines (Basel). 2019 Jun 29;10(7):430. doi: 10.3390/mi10070430. Micromachines (Basel). 2019. PMID: 31261887 Free PMC article.
An ~8 m-thick p-type 3C-SiC epilayer was grown on a silicon-on-insulator (SOI) wafer, which was followed by a ~2 m-thick epilayer of heavily n-type (n(+)) 3C-SiC in order to form conductive traces and the electrode sites. Diodes formed between the p and n(+) …
An ~8 m-thick p-type 3C-SiC epilayer was grown on a silicon-on-insulator (SOI) wafer, which was followed by a ~2 m-thick epilayer of heavily …
Impact Fatigue Life of Adhesively Bonded Composite-Steel Joints Enhanced with the Bi-Adhesive Technique.
Akhavan-Safar A, Eisaabadi Bozchaloei G, Jalali S, Beygi R, Ayatollahi MR, da Silva LFM. Akhavan-Safar A, et al. Materials (Basel). 2023 Jan 2;16(1):419. doi: 10.3390/ma16010419. Materials (Basel). 2023. PMID: 36614758 Free PMC article.
Accordingly, in this study, the use of the bi-adhesive technique is proposed to improve the durability of composite-metal single-lap joints (SLJs) under impact fatigue loading conditions. J-N (energy-life) method is also used to analyze the experimental data obtained. Acco …
Accordingly, in this study, the use of the bi-adhesive technique is proposed to improve the durability of composite-metal single-lap joints …
Does Ramadan Fasting Adversely Affect Cognitive Function in Young Females?
Ghayour Najafabadi M, Rahbar Nikoukar L, Memari A, Ekhtiari H, Beygi S. Ghayour Najafabadi M, et al. Scientifica (Cairo). 2015;2015:432428. doi: 10.1155/2015/432428. Epub 2015 Nov 30. Scientifica (Cairo). 2015. PMID: 26697263 Free PMC article.
Data were obtained from participants of two fasting (n = 9) and nonfasting (n = 8) groups at three periods of the study (before Ramadan, at the third week in Ramadan, and after Ramadan). ...
Data were obtained from participants of two fasting (n = 9) and nonfasting (n = 8) groups at three periods of the study (befor …
Suicide Reattempt Risk Factors: A Cross-Sectional Study Using Mashhad's Population-Based Registry, 2019-2022.
Moradi A, Nikbakht F, Taghipour A, Fathi HR, Beygi B, Ghasemi K, Amiri Z, Mosafarkhani E. Moradi A, et al. Iran J Public Health. 2025 Apr;54(4):860-869. doi: 10.18502/ijph.v54i4.18425. Iran J Public Health. 2025. PMID: 40321918 Free PMC article.
The overall rate of suicide reattempt was 10.1% (n=580). Suicide reattempts were more prevalent among men (55.5% of reattempts, n=322), individuals with mental disorders (16.0%, n=93), substance users (7.8%, n=45), single persons (66.6%, n=386), …
The overall rate of suicide reattempt was 10.1% (n=580). Suicide reattempts were more prevalent among men (55.5% of reattempts, n …
18 results